Pharma Blog Watch

OxyContin Patent Settlement (Patent Baristas)
In his entry, blogger Stephen Albainy-Jenei discusses Purdue's settlement with Endo in a suit over OxyContin patents, which had been previously ruled to be unenforceable due to "misrepresentations to the U.S. Patent and Trademark Office about the painkiller's effectiveness."